
HONG KONG, Jul 27, 2020 - (ACN Newswire) - Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focusing on the development of novel therapeutics to address global unmet medical needs, today is pleased to announce that its Class A Ordinary Shares has commenced trading on the Professional Compartment of Euronext in...
Read more: Aptorum Group Becomes the First Nasdaq Listed Biopharmaceutical Company Admitted to Trading on...